CVE-2022-1554: clinical-genomics clinical-genomics/scout Absolute Path Traversal
CVSS: 7.5v3.1HighModified
AliasesGHSA-694v-63fq-fmr4PYSEC-2026-749
Published 03-05-2022Last modified 03-08-2024
Vulnerability summary
CVE-2022-1554 is a high (CVSS 7.5) Absolute Path Traversal vulnerability in clinical-genomics clinical-genomics/scout. EPSS estimates a 1.37% chance of exploitation in the next 30 days, higher than 71.4% of scored vulnerabilities. 1 public exploit is recorded.
CVSS score
7.5/10
010
High · v3.1 (NVD)EPSS score
1.37%
0%100%
Low · +0.02 pp in 30 daysKEVNot listedIn no KEV catalog
RansomwareNone recordedNo known use recorded
Public exploits1reference
Timeline
- 03-05-2022PublishedVulnerability first disclosed.
- 03-08-2024Last modifiedVulnerability information updated.
Description
Path Traversal due to `send_file` call in GitHub repository clinical-genomics/scout prior to 4.52.
CVSS metrics
5 scores · 3 sources · 3 versionsHigh 7.5Preferred score · NVD (NIST)
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:NSourcesSingle source
Medium 6.8Preferred score · CVE.org (CNA)
CVSS:3.0/AV:N/AC:L/PR:L/UI:R/S:U/C:L/I:H/A:LSourcesAll 3 agree
- OSV · PypiEcosystem advisory · calculated6.8MediumCVSS:3.0/AV:N/AC:L/PR:L/UI:R/S:U/C:L/I:H/A:L
- NVDNIST6.8MediumCVSS:3.0/AV:N/AC:L/PR:L/UI:R/S:U/C:L/I:H/A:L
Medium 5.0Preferred score · NVD (NIST)
AV:N/AC:L/Au:N/C:P/I:N/A:NSourcesSingle source
EPSS trend
Probability
1.37%
Chance of exploitation in the next 30 days
Percentile
71%
Versus all other CVEs
30-day change
+0.02 pp
From 1.34% on 19-09-2026
19-09-202619-10-2026
EPSS score1.37%
Known exploited
Compare KEV catalogsNot in any of the 3 tracked catalogs.
Public exploits
1 foundExploit Reference (huntr.dev)
Maturity: unknown
Weaknesses
CWE · root cause- CWE-36Absolute Path TraversalThe product uses external input to construct a pathname that should be within a restricted directory, but it does not properly neutralize absolute path sequences such as "/abs/path" that can resolve to a location that is outside of that directory.
- CWE-22Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')The product uses external input to construct a pathname that is intended to identify a file or directory that is located underneath a restricted parent directory, but the product does not properly neutralize special elements within the pathname that can cause the pathname to resolve to a location that is outside of the restricted directory.
Affected systems
Clinical-genomics2 products
- clinical-genomics/scout≥ unspecified, < 4.52
- scout< 4.52
PyPI1 product
- scout-browser< 4.52
2 vendors · 3 products
References
9 links- huntr.dev/bounties/7acac778-5ba4-4f02-99e2-e4e17a81e600X Refsource CONFIRMWEBExploitPatchThird Party Advisory
- github.com/clinical-genomics/scout/commit/952a2e2319af2d95d22b017a561730feac086ff1X Refsource MISCWEBPatchThird Party Advisory
